Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
PLX: Protalix BioTherapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
PLX
The Story
PLX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Operating margin
25.9%
ROIC
20.6%
Financially safe
Strong
Debt / equity
0.13×
Interest coverage
12.9×
Current ratio
3.15×
Valuation
Unrated
P/E ratio
12.3×
Protalix BioTherapeutics, Inc.
PLX
New York Stock Exchange Arca
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Protalix BioTherapeutics, Inc.
PLX
New York Stock Exchange Arca
·
USD
·
Closed
$2.37
+4.41%
$2.37
+$0.10 (4.41%)
52W Range
54th
pctl
Volume
1.67×
avg
Mkt Cap
190.95M
USD
P/E
12.3
TTM
Div Yield
–
ann
52W Range
54th
pctl
Volume
1.67×
avg
Market Cap
190.95M
USD
P/E Ratio
12.3
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings